{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:18:34Z","timestamp":1790619514300,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","award":["113202004"],"award-info":[{"award-number":["113202004"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejps.2017.01.025","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T14:15:14Z","timestamp":1485180914000},"page":"205-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3300-7084","authenticated-orcid":false,"given":"A.C.","family":"van der Vossen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"van der Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.S.N.M.","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Vulto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Hanff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejps.2017.01.025_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/17425247.2014.951633","article-title":"Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups","volume":"12","author":"Aleksovski","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2017.01.025_bb0010","series-title":"Clarke's Analysis of Drugs and Poisons [Internet]","year":"2016"},{"key":"10.1016\/j.ejps.2017.01.025_bb0015","series-title":"Reflection Paper: Formulations of Choice for the Paediatric Population London: European Medicines Agency","author":"Committee for Human Medicinal Products (CHMP)","year":"2006"},{"key":"10.1016\/j.ejps.2017.01.025_bb0020","series-title":"Background Review for Cyclodextrins Used as Excipients","author":"Committee for Human Medicinal Products (CHMP)","year":"2014"},{"key":"10.1016\/j.ejps.2017.01.025_bb0025","series-title":"London: European Medicines Agency","article-title":"Background review for the excipient propylene glycol","author":"Committee for Human Medicinal Products (CHMP)","year":"2014"},{"issue":"6","key":"10.1016\/j.ejps.2017.01.025_bb0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/03639040500214738","article-title":"Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use","volume":"31","author":"Holvoet","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2017.01.025_bb0035","series-title":"Toxicological Evaluation of Certain Food Additives with a Review of General Principles and of Specifications","author":"Joint FAO\/WHO Expert Committee on Food Additives, editor","year":"1974"},{"key":"10.1016\/j.ejps.2017.01.025_bb0040","series-title":"Toxicological Evaluation of Certain Food Additives","author":"Joint FAO\/WHO Expert Committee on Food Additives Meeting, World Health Organization, International Program on Chemical Safety, editors","year":"1982"},{"issue":"4","key":"10.1016\/j.ejps.2017.01.025_bb0045","first-page":"254","article-title":"Chemical stability of extemporaneously prepared Lorazepam suspension at two temperatures","volume":"9","author":"Lee","year":"2004","journal-title":"J. Pediatr. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejps.2017.01.025_bb0050","first-page":"36","article-title":"The accuracy and precision of measuring Lorazepam from three liquid preparations","volume":"10","author":"Lee","year":"2005","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.01.025_bb0055","series-title":"Pediatric & Neonatal Lexi-Drugs\u00ae","author":"Lexicomp Online\u00ae","year":"2016"},{"issue":"1","key":"10.1016\/j.ejps.2017.01.025_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10903127.2012.722177","article-title":"The 60-day temperature-dependent degradation of midazolam and Lorazepam in the prehospital environment","volume":"17","author":"McMullan","year":"2013","journal-title":"Prehosp. Emerg. Care"},{"issue":"11","key":"10.1016\/j.ejps.2017.01.025_bb0070","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.clinthera.2008.11.018","article-title":"Optimizing oral medications for children","volume":"30","author":"Mennella","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2017.01.025_bb0075","series-title":"The Merck Index: an Encyclopedia of Chemicals, Drugs, and Biologicals","author":"O'Neil","year":"2006"},{"issue":"11","key":"10.1016\/j.ejps.2017.01.025_bb0090","first-page":"1628","article-title":"Facile thermal rearrangement of Lorazepam and Oxazepam","volume":"51","author":"Siddegowda","year":"2012","journal-title":"Indian J. Chem. Sect. B Org. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejps.2017.01.025_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2125.2011.03982.x","article-title":"The availability and age-appropriateness of medicines authorized for children in The Netherlands","volume":"72","author":"van Riet-Nales","year":"2011","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717300490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717300490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T18:51:28Z","timestamp":1536087088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717300490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":16,"alternative-id":["S0928098717300490"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.01.025","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}